The Vital Role of Annual Flu Vaccines in Protecting Public Health

Experts review how influenza vaccines have advanced in recent years and discuss misconceptions that people may have about standard-dose and high-dose flu vaccines.

An expert panel discusses the development of recombinant and cell-based vaccines and new types of influenza vaccines being explored.

Experts examine the yearly modifications in the formulations of flu vaccines and explore the variations in the adverse events experienced across different types of flu vaccines.

A panel of experts discuss those most at risk for complications from the flu, and how flu vaccines may benefit them.

An expert panel examines the distinctions among the 3 primary recommended flu vaccines for individuals aged 65 and above, assessing their efficacy compared with standard-dose flu vaccines.

Adam C. Welch, PharmD, MBA, FAPhA, evaluates the impact of yearly flu vaccinations on curtailing the spread of influenza among communities and populations.

Experts analyze the process by which the Advisory Committee on Immunization Practices formulates vaccine recommendations and updates them, and the implications and effects of these decisions.

Specialists assess how flu vaccines enhance immunity across various age groups against influenza.

A panel of experts review the criteria used to select a specific high-dose flu vaccine formulation for immunization.

Experts discuss strategies that can be employed to communicate the significance of yearly flu vaccines to patients and improve patient- centered care offered by pharmacists.

Randy McDonough, PharmD, MS, BCGP, BCPS, FAPhA, discusses his experience with vaccine hesitancy and factors that may lead to it.

Chad Worz, PharmD, BCGP, FASCP, discusses how vaccine hesitancy and misinformation about flu vaccines create barriers to annual flu immunizations.

An expert panel reviews the signs of vaccine hesitancy and how pharmacists can address patient concerns.

Chad Worz, PharmD, BCGP, FASCP, and the panel review the NUDGE-FLU Trial and discuss the study design, outcomes, and how similar nudges can be incorporated into practice.

Experts discuss the social determinants that can affect the rates of flu immunizations and strategies to boost immunization rates.